Skip to main content
SpringerLink
Log in

Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

The herpes simplex virus thymidine kinase gene is the most widely utilized toxin for selective killing of carcinoma cells. Expression of the viral thymidine kinase gene renders cells sensitive to the toxic effects of nucleoside analogs such as ganciclovir. An advantage of this system is the “bystander effect” whereby thymidine kinase transduced tumor cells elicit a toxic effect on surrounding nontransduced tumor cells. Ovarian carcinoma appears to be an ideal candidate for gene therapy as the majority of women present with advanced stage disease, have poor prognosis for long-term survival and have the disease confined within the peritoneal cavity. Therefore the utility of an adenoviral vector to elicit an in vitro by-stander effect in ovarian carcinoma cells and the therapeutic efficacy of such a system in vivo was undertaken. Immunocompetent animals were utilized to determine the maximum dose of adenovirus that could be administered without any undesirable side effects and that preimmunization had no effects on subsequent challenge. SCID mice were orthotopically transplanted with human ovarian carcinoma cells and, after establishment of tumor, given a recombinant adenovirus expressing either the herpes simplex virus thymidine kinase or the Escherichia coli β-galactosidase gene. Half the animals from each viral group were treated with either a ganciclovir regiment (50 mg/kg daily for 14 days) or an equal volume of serum-free media. A subset of mice were killed following drug treatment and analyzed for tumor reduction. The remaining animals were followed daily for survival. The animals treated with the recombinant adenovirus expressing the herpes simplex virus thymidine kinase gene and ganciclovir had significant reduction in overall tumor burden and demonstrated statistically significant prolongation in overall survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AdCMVHSVtk :

Recombinant adenovirus expressing

HSVtk·AdCMVLacZ :

Recombinant adenovirus expressing β-galactosidase

GCV :

Ganciclovir

Pfu :

plaque forming units

moi :

multiplicity of infection

References

  1. Whartenby KA, Abboud CN, Marrogi AJ, Ramesh R, Freeman SM (1995) Biology of disease: the biology of cancer gene therapy. Laboratory Investigation 72:131–145

    Google Scholar 

  2. Moolten F (1986) Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 46:5276–5281

    Google Scholar 

  3. Abe A, Takeo T, Emi N, Tanimoto M, Ueda R, Yee J-K, Friedmann T, Saito H (1993) Transduction of a drug-sensitive toxic gene into human leukemia cell lines with a novel retroviral vector. Proc Soc Exp Biol Med 203:354–359

    Google Scholar 

  4. Mullen CA, Kilstrup M, Blaese RM (1992) Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA 89:33–37

    Google Scholar 

  5. Culver KW, Ram Z, Walbridge S, Ishii H, Oldfield EH, Blaese RM (1992) In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors. Science 256:1550–1552

    Google Scholar 

  6. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, Abraham GN (1993) The “bystander effect”: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53:5274–5283

    Google Scholar 

  7. Elion GB, Furman PA, Fyfe JA, DeMiranda P, Beauchamp L, Schaeffer HJ (1977) Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci USA 74:5716–5720

    Google Scholar 

  8. Furman PA, McGujirt PV, Keller PM, Fyfe JA, Elion GB (1980) Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information. Virology 102:420–430

    Google Scholar 

  9. Becker TC, Noel RJ, Coats WS, Gomez-Foix AM, Alam T, Gerard RD, Newgard CB (1994) Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 43:161–189

    Google Scholar 

  10. Rosenfeld ME, Feng M, Michael SI, Siegal GP, Alvarez RD, Curiel DT (1995) Adenvorial-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir. Clinical Cancer Res 1:1571–1580

    Google Scholar 

  11. Feng M, Cabrera G, Deshane J, Scanlon K, Curiel D (1995) Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme. Cancer Res 55:2024–2028

    Google Scholar 

  12. Yu D, Wolf JK, Scanlon M, Price JE, Hung MC (1993) Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res 53:891–898

    Google Scholar 

  13. Freeman SM, McCune C, Angel C, Abraham GN, Abboud CN (1992) Treatment of ovarian carcinoma using HSV-TK gene modified vaccine regulatory issues. Hum Gene Ther 3:342–349

    Google Scholar 

  14. Sobol RE, Scanlon KJ, editors 1995 Clinical Protocols. Cancer Gene Ther 2:225-234

  15. Simon RH, Engelhardt JF, Yang Y, Zepeda M, Weber-Pendleton S, Grossman M, Wilson JM (1993) Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther 4:771–780

    Google Scholar 

  16. Jaffe HA, Danel C, Longenecker G, Metzger M, Setoguchi Y, Rosenfeld MA, Gant TW, Thorgeirsson SS, Stratford-Perricaudet LD, Perricaudet M, Pavirani A, Lecocq J-P, Crystal RG (1992) Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet 1:372–378

    Google Scholar 

  17. Yang Y, Raper SE, Cohn JA, Engelhardt JF, Wilson JM (1993) An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc Natl Acad Sci USA 90:4601–4605

    Google Scholar 

  18. Quantin B, Perricaudet LD, Tajbakhsh S, Mandel J-L (1992) Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA 89:2581–2584

    Google Scholar 

  19. Bass C, Cabrera G, Elgavish A, Robert B, Siegal GP, Anderson SC, Maneval DC, Curiel DT (1995) Recombinant adenovirus-mediated gene transfer to genito-urinary epithelium in vitro and in vivo. Cancer Gene Ther 2:97–104

    Google Scholar 

  20. Liu T-J, Zhang W-W, Taylor DL, Roth JA, Goepfert H, Clayman GL (1994) Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 54:3662–3667

    CAS  PubMed  Google Scholar 

  21. Deshane J, Siegal GP, Alvarez RD, Wang M, Feng M, Cabrera G, Liu T, Kay M, Curiel DT (1995) Targeted tumor killing via an intracellular antibody against erbB-2. J Clinic Invest 96: 2980–2989

    Google Scholar 

  22. Smythe WR, Hwang HC, Amin KM, Eck SL, Davidson BL, Wilson JM, Kaiser LR, Albelda SM (1994) Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res 54:2055–2059

    Google Scholar 

  23. Smythe WR, Kaiser LR, Hwang HC, Amin KM, Pilewski JM, Eck SJ, Wilson JM, Albelda SM (1994) Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann Thor Surg 57:1395–1401

    Google Scholar 

  24. Hwang HC, Smythe WR, Elshami AA, Kucharczuk JC, Amin KM, Williams JP, Litzky LA, Kaiser LR, Albelda SM (1995) Gene therapy using adenovirus carrying the herpes simplexthymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer. Am J Respir Cell Mol Biol 13:7–16

    Google Scholar 

  25. Bonnekoh B, Greenhalgh DA, Bundman DS, Eckhardt JN, Longley MA, Chen S-H, Woo SLC, Roop DR (1995) Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene transfer in vivo. J Invest Dermatol 104: 313–317

    Google Scholar 

  26. O'Malley BW Jr, Chen S-H, Schwartz MR, Woo SLC (1995) Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res 55: 1080–1085

    Google Scholar 

  27. Sobol RE, Scanlon KJ, editors 1995 Clinical Protocols. Cancer Gene Ther 2:67–74

  28. Yang Y, Nunes FA, Berencsi K, Furth EE, Gšnczšl E, Wilson JM (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91: 4407–4411

    Google Scholar 

  29. Yang Y, Trinchieri G, Wilson JM (1995) Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Medicine 1:890–893

    Google Scholar 

  30. Wilson C, Kay MA (1995) Immunomodulation to enhance gene therapy. Nature Med 1:887–889

    Google Scholar 

  31. Fang B, Eisensmith RC, Wang H, Kay MA, Cross RE, Landen CN, Gordon G, Bellinger DA, Read MS, Hu PC, Brinkhous KM, Woo SLC (1995) Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum Gene Ther 6: 1039–1044

    Google Scholar 

  32. Vile RG, Hart IR (1993) Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res 53:3860–3864

    Google Scholar 

  33. Osaki T, Tanio Y, Tachibana I, Hosoe S, Kumagai T, Kawase I, Oikawa S, Kishimoto T (1994) Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res 54:5258–5261

    CAS  PubMed  Google Scholar 

  34. Garver RI, Goldsmith KT, Rodu B, Hu P-C, Sorscher EJ (1994) Strategy for achieving selective killing of carcinomas. Gene Ther 1:46–50

    Google Scholar 

  35. DiMaio JM, Clary BM, Via DF, Coveney E, Pappas TN, Lyerly HK (1994) Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo. Surgery 116:205–213

    Google Scholar 

  36. Manome Y, Abe M, Hagen MF, Fine HA, Kufe DW (1994) Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir. Cancer Res 54:5408–5413

    Google Scholar 

  37. Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M, Ishii N, Tamaoki T, Shiku H, Nagataki S (1995) Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promoter. Cancer Res 55:3105–3109

    Google Scholar 

  38. McPhaul MJ, Deslypere J-P, Allman DR, Gerard RD (1993) The adenovirus-mediated delivery of a reporter gene permits the assessment of androgen receptor function in genital skin fibroblast cultures. J Biol Chem 268:26063–26066

    Google Scholar 

  39. Hayashi Y, DePaoli AM, Burant CF, Refetoff S (1993) Expression of a thyroid hormone-responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroid hormone receptor. J Biol Chem 269:23872–23875

    Google Scholar 

  40. Varley AW, Coulthard MG, Meidell RS, Gerard RD (1995) Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes Proc Natl Acad Sci USA 92:5346–5350

    Google Scholar 

  41. Kaneko S, Hallenbeck P, Kotani T, Nakabayashi H, McGarrity G, Tamaoki T, Anderson WF, Chiang YL (1995) Adenovirusmediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res 55:5283–5287

    Google Scholar 

  42. Tanaka T, Kanai F, Okabe S, Yoshida Y, Wakimoto H, Hamada H, Shiratori Y, Lan K-H, Ishitobi M, Omata M (1996) Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro. Cancer Res 56:1341–1345

    Google Scholar 

  43. National Institutes of Health 1985 Guide for the care and use of laboratory animals. Bethesda, NIH publication no 85-23

Download references

Author information

Authors and Affiliations

  1. Gene Therapy Program, Comprehensive Cancer Center Department of Medical Genetics, University of Alabama at Birmingham, 35294, Birmingham, AL, USA

    M. E. Rosenfeld, M. Wang, G. P. Siegal, R. D. Alvarez, G. Mikheeva & V. Krasnykh

  2. Gene Therapy Program, Comprehensive Cancer Center, Department of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, 6th Avenue South, Room 620, 35294, Birmingham, AL, USA

    D. T. Curiel

Authors
  1. M. E. Rosenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. P. Siegal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. D. Alvarez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Mikheeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V. Krasnykh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. T. Curiel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenfeld, M.E., Wang, M., Siegal, G.P. et al. Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma. J Mol Med 74, 455–462 (1996). https://doi.org/10.1007/BF00217521

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00217521

Key words

Search

Navigation